With the recent routine random inspection carried out by the Maharashtra Food and Drug Administration (FDA) has seized 33 not-of standard drugs in month of January. The umber of sub-standard drugs found in January is more than the month of December with only 20 not-of-standard drugs.

The sample testing carried out by the agency at their drug testing laboratory in Mumbai. These samples were tested and declared as sub-standard and advised to stop their use, sale and distribution as they are unfit for prescription by the medical practitioners.

Manufacturers from the tax-free state of Himachal Pradesh (HP) has accounted for major share in January with 13 not-of-standard drugs and seven in December.

The well-known drug manufacturers who has found distributing these sub-standard drugs in January includes: Captab Biotech, HP for Diavox-250 tablets, UltraTech Pharmaceutical, HP for Omox-Clv (LB) dry syrup, Scoot-Edil Pharmacia, HP for Fotaz-O dry syrup, Zydus Animal Health, Gujarat for Belamyl Veterinary B-complex liver extract with vitamin B-12 injection, Coax Bioremedies, Harayana for multi-vitamin infusion, Hab Pharmaceuticals & Research Limited, Uttarakhand for Cid-O-Rab-D tablets, Ciron Drugs & Pharmaceuticals, Maharashtra for iron dextran injection, Schon Pharmaceuticals, Madhya Pradesh for Kapril-H (Ramipril and hydrochlorothiazide) tablets, Numech Healthcare, MP for Pesolen-10 tablets.

In December the list of manufacturers includes: Packsules, MP for Chloramphenicol eye ointment, Zest Pharma, MP for Azest-500 tablets, Bayer Pharmaceuticals, Pune for Resochin tablets, Shervotec Pharmaceuticals, HP for Cefixime oral dry syrup, Hab Pharmaceuticals & Research Limited, Uttarakhand for multi-9 multi-vitamin tablets, Avenue Remedies, HP for Parazym (digestive enzymes), Curetech Formulation, HP for Pantafol tablets and Sri Vishnuram Company, Tamil Nadu for super fine absorbent gauze.

The other companies listed in the December and January for not complying with IP requirements includes: Talent Healthcare, Uttarakhand for X-Pod dry syrup, Nova BeautyCare Products, Nashik for Nova Deep Cleansing milk aloevera, Universal Healthcare, Haryana for Clozotic ear drops, Nulife Pharmaceutical, pune for Clotrin-AC ear drops, SAAR Biotech, HP for acelyn-plus suspension aceclofenac and paracetamol suspension, Pharma Link Laboratories, Maharashtra for carbilazen tablets, DM Pharma, HP for POKI-KID tablets and Panon tablets, Precise Biopharma, Maharashtra for Zerotuss oral suspension, Ross Robbinz Biotech, HP for Rossclave Duo suspension, Sawan Industries, MP for Mahuri Heena Brown Tone, ZEE Laboratories for Susee Suspension, Agam & Gem Laboratories, Daman for multi life plus tablets, Santo Formulation, HP for Sanfer, Shiru Pushpam Surgicals, AP for roller bandage schedule F (II), Cosmos Research Lab, Punjab for Kantoclav Dry syrup, Shiva Biogenetic Pharmaceuticals, HP for Alcid-MPS, Gujarat Pharmaceuticals for FEM-20 tablets, Alps Pharmaceuticals, Uttarakhand for cypro-L syrup, Healthy Life Pharma, Maharahstra for entacid, JCPL Pharma, Maharashtra for Diria capsules, Skymap Pharmaceuticals, Uttarakhand for pantaprazole enteric coated tablets, FDC Ltd, Goa for Zilos 50 tablets, Smilax Healthcare, HP for Lupizyme cardamom flavoured digestive enzymes, Medipol Pharmaceuticals, HP for amiclox tablets, Kanha Biogenetic Laboratories, HP for Remit-20 rabeprazole tablets and APJ Laboratories, HP for Onvin-4 MD ondasetron mouth dissloving tablets.